
Onconic Therapeutics signs Nordic distribution deal for GERD treatment Jaqbo
Onconic Therapeutics, a subsidiary of Jeil Pharmaceutical, said Thursday that it has signed a supply agreement with a Swedish pharmaceutical company for the distribution and sale of Jaqbo (zastaprazan), a P-CAB-based treatment for gastroesophageal reflux …